Profile: BTG PLC (BTG.L)

BTG.L on London Stock Exchange

662.00GBp
19 Sep 2014
Price Change (% chg)

4.50p (+0.68%)
Prev Close
657.50p
Open
668.00p
Day's High
671.00p
Day's Low
659.00p
Volume
791,446
Avg. Vol
444,265
52-wk High
671.10p
52-wk Low
365.30p

Search Stocks
BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology. Its focus within Specialty Pharmaceuticals is on antidote products that are used within hospitals. Its interventional medicine products are embolisation and drug-eluting beads used primarily to treat patients with liver tumors and Brachytherapy products used mainly for early-stage prostate cancer. Licensing & Biotechnology business area consists of licensed products and programmes and generates royalties for BTG. The Company’s subsidiaries include BTG International (Holdings) Ltd, Provensis Ltd, BTG International Ltd, BTG Employee Share Schemes Ltd and BTG Management Services Ltd.

Company Address

BTG PLC

5 Fleet Place
LONDON   ENG   EC4M 7RD
P: +4420.75750000
F: +4420.75750010

Search Stocks